MedTrace Logo

MATTERS Study - Mistral Percutaneous Tricuspid Valve Repair FIM Study

NCT04071652 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2023-10-19

No results posted yet for this study

Summary

The Mistral is an investigational device intended for percutaneous trans-catheter repair in high risk for surgery individuals suffering from functional Tricuspid Regurgitation (TR).

The device system is to be used only in accordance with the approved Investigational Plan on subjects who have signed an informed consent form. Device use is limited to the approved study investigators.

Conditions

  • Tricuspid Valve Regurgitation

Interventions

DEVICE

Mistral implantation

Mistral implant is implanted in the Tricuspid valve

Sponsors & Collaborators

  • Mitralix

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-08
Primary Completion
2020-10-01
Completion
2023-02-28

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04071652 on ClinicalTrials.gov